Author reply to comment on "atorvastatin safety in Kawasaki disease patients with coronary artery aneurysms"

Pediatr Cardiol. 2014 Jan;35(1):94-5. doi: 10.1007/s00246-013-0806-1. Epub 2013 Oct 15.

Authors

Cedric Manlhiot¹, Brian W McCrindle

Affiliation

¹ Department of Pediatrics, Labatt Family Heart Centre, University of Toronto, The Hospital for Sick Children, Toronto, ON, Canada.

PMID: 24126955
DOI: 10.1007/s00246-013-0806-1

No abstract available

Publication types

Letter
Comment

MeSH terms

Atorvastatin
Child Development / drug effects*
Coronary Aneurysm*
Coronary Vessels*
Female
Heptanoic Acids*
Humans
Inflammation / drug therapy*
Male
Mucocutaneous Lymph Node Syndrome*
Pyrroles*

Substances

Heptanoic Acids
Pyrroles
Atorvastatin